BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
The majority of the work will be completed in 2021 to start clinical trials as early as possible during 2022... Nov 26
-Advertisements-